City

Bloomington (1)

Boston (1)

Danville (1)

Detroit (1)

Honolulu (1)

Oakland (1)

Pasadena (1)

Valencia (1)

Condition

Cardiovascular Diseases (1)

Cardiovascular Events (1)

Obesity (1)

Renal Disease (1)

Type 2 Diabetes (1)

Type 2 Diabetes Mellitus (1)

Type2 Diabetes (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Phase

Sponsor

Ana Palanca (1)

Brigham and Women's Hospital (1)

Kaiser Permanente (1)

Collaborator

Patient-Centered Outcomes Research Institute (2)

Geisinger Clinic (1)

HealthPartners Institute (1)

Henry Ford Health System (1)

McGill University (1)

VA Boston Healthcare System (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (3)

Study Type

Observational (3)

glp-1ra

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

GLP-1 Receptor Agonists on Efficacy and Persistence, Adherence

Completed

Type 2 Diabetes
Obesity

GLP-1RA
+3 more

Valencia, Spain

INCLIVA

Sep 6, 2022

Comparison of Type 2 Diabetes Pharmacotherapy Regimens

Recruiting

Type 2 Diabetes Mellitus
Cardiovascular Diseases

SU
+13 more

Oakland, California
+5 more

Oct 18, 2022

Four Second Line Pharmacological Strategies in Type 2 Diabetes

Active, not recruiting

Cardiovascular Events
+2 more

SGLT2 inhibitor
+3 more

Boston, Massachusetts

Brigham and Women's Hospital

Feb 17, 2022